Are Clean Energy Tenants CRE’s New Savior?
As life science demand wanes, developers are increasingly marketing new projects to Massachusetts’ growing clean energy sector, flush with funding from venture capital and new federal programs.
Moderna Buys GMP Plant in Marlborough for $91M
Moderna will open a new 140,000-square-foot biomanufacturing plant next year that’s being developed by Oxford Properties Group on a 24-acre site.
Oxford Buys Second cGMP Property in Marlborough
A biomanufacturing facility nearing completion in Marlborough was acquired by Oxford Properties for $125 million through a sale-leaseback.
New Owners Plan Speculative cGMP Project in Canton
The new owners of a Canton call center plan a speculative redevelopment into a 126,460-square-foot cGMP facility.
130-Acre Braintree Site Marketed for Biomanufacturing Tenants
A 130-acre site near the Braintree-Weymouth line would become a new biomanufacturing hub under plans by a Hingham developer.
310K SF Life Science Project Proposed in Woburn
After recently completing a 289-unit apartment complex in Woburn, a Boston developer submitted plans to redevelop a 14-acre nearby industrial site as lab and biomanufacturing space.
Alexandria Buys Andover Office Properties for $341M
Life science development heavyweight Alexandria Real Estate Equities has paid $341 million for eight properties in Andover’s Minuteman Park, including 1.3 million square feet of existing buildings and potential for a new biomanufacturing complex.
